glp-1 side effect management Part 2 of a 3-Part Series; Medications for Weight Loss Side Effect Profile of GLP-1

While the FDA has concluded that there is no evidence that GLP-1s cause suicidal ideation, researchers are continuing to carefully evaluate any changes in mental health

Treece-Birch J

Licensed for BMI 30 kg/m or 28 kg/m with comorbidities Naltrexone-bupropion combination (Mysimba) : Licensed in the UK but with limited NHS availability as NICE terminated its technology appraisal

We will verify your insurance and set you up with a licensed provider

Communication with a healthcare provider is key to ensuring safe and effective use of semaglutide

PMCID: PMC2935185 ) Arnold DM, Nazi I, Warkentin TE, Smith JW, Toltl LJ, George JN, Kelton JG (2013) Approach to the diagnosis and management of drug-induced immune thrombocytopenia